Back
FibroGen 10K Form
Sell
46
FGEN
FibroGen
Last Price:
1.21
Seasonality Move:
4.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-06 | 10Q | FGEN/FibroGen Quarterly |
| 2023-08-07 | 10Q | FGEN/FibroGen Quarterly |
| 2023-05-08 | 10Q | FGEN/FibroGen Quarterly |
| 2022-11-07 | 10Q | FGEN/FibroGen Quarterly |
| 2022-08-08 | 10Q | FGEN/FibroGen Quarterly |
| 2022-05-09 | 10Q | FGEN/FibroGen Quarterly |
Receive FGEN News And Ratings
See the #1 stock for the next 7 days that we like better than FGEN
FGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $147.75M |
|---|---|
| Cash Flow: | $-59.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.29 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.45000 |
|---|---|
| Net Income (TTM): | $-240.46M |
| Gross Margin: | $128.9M |
| Return on Equity: | 0% |
| Return on Assets: | -52.2% |
FibroGen Earnings Forecast
Key FibroGen Financial Ratios
- The Gross Profit Margin over the past 11 years for FGEN is 87.24%.
- The Selling, General & Administrative Expenses for FGEN have been equal to 78.00% of Gross Profit Margin.
- The Research & Development expenses have been 191.44% of Revenue.
- The Interest Expense is -5.46% of Operating Income.
- The Net Earning history of FGEN is -192.37% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
FibroGen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FGEN |
| CUSIP: | 31572Q |
| Website: | fibrogen.com |
Debt
| Debt-to-Equity Ratio: | -0.32 |
|---|---|
| Current Ratio: | 1.41 |
| Quick Ratio: | 1.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 8 |